EGFR cooperates with impaired Hippo pathway signalling, leading to tissue overgrowth [108] and also with the overexpression of the bantam micro-RNA (which is a downstream target of Yki [225, 226] and also of EGFR signalling [227]), leading to overgrown invasive tumours [109]. The gene discussed is EGFR; the disease is neoplasm.